RESULTS
TABLE 1: CLINICO DEMOGRAPHIC PROFILE OF HEMODIALYSIS AND PERITONEAL DIALYSIS PATIENTS
Clinicodemographic | HEMODIALYSIS | PERITONEAL DIALYSIS | p-values |
Age (WHO age classification) 19-24 25-44 45-60 | 3 (5.0%) 24 (40.0%) 33 (55%) | 4 (15.4%) 8 (30.8%) 14 (53.8%) | 0.244 (There is no significant association between the age and the type of treatment of the CKD patients.) |
Sex |
Male | 22 (36.7%) | 15 (57.7%) | 0.071 (There is no significant association between the sex and the type of treatment of the CKD patients.) |
Female | 38 (63.3%) | 11 (42.3%) |
Social support (Patient’s being accompanied by caregiver during HD/ consult) |
Yes | 60 (100%) | 26 (100%) | - (no test can be performed since all have social support) |
NO | 0 | 0 |
Financial SUPPORT (MALASAKIT/ SAVINGS/FAMILY) |
YES | 60 (100%) | 26 (100%) | (no test can be performed since all have financial support) |
NO | 0 | 0 |
| | | |
With comorbidities |
NO | 56 (93.3%) | 24 (92.3%) | 0.864 (There is no significant association between patients with/without comorbidities and the type of treatment of the CKD patients.) |
YES | 4 (6.7%) | 2 (7.7%) |
WHO Performance status |
0 | 2 (3.3%) | 0 | 0.397 (There is no significant association between the WHO Performance Status and the type of treatment of the CKD patients.) |
1 | 46 (76.7%) | 22 (84.6%) |
2 | 6 (10%) | 4 (15.4%) |
3 | 4 (6.7%) | 0 |
4 | 2 (3.3%) | 0 |
5 | | |
Area of Residence | | | 0.508 (There is no significant association between the area of residence and the type of treatment of the CKD patients.) |
CAR | 59 (98.3%) | 26 (100%) |
Outside CAR | 1 (1.7%) | 0 |
Table 1 shows the Demographic data wherein out of 112 respondents, a total of 86 adult CKD patients gave their consent, underwent and completed the study. It shows that majority of the population of patients undergoing hemodialysis and peritoneal dialysis where under the age group of 45-60 which is the middle aged group which has no statistically significant association between age distribution and dialysis modality (p = 0.244). With regards to sex, a higher proportion of males were in the PD group (57.7%) compared to the HD group (36.7%) however it was not statistically significant at the 0.05 level. Both groups also showed that most of the HD and PD patients where being supported financially as well as socially. When it comes to comorbidities pertaining to physical disability their are more patient observed in the HD group, however the difference between groups was not also statistically significant. Almost all of the patients in both groups are also residing in the Cordillera Administrative Region. In both groups, majority were functionally independent, with the majority in both groups falling under Performance Status 1 (HD: 76.7%, PD: 84.6%). No patients in the PD group had Performance Status levels 0, 3, or 4. Despite these differences, there was no statistically significant association between WHO Performance Status and dialysis type (p = 0.397)
In this study, none of the examined clinicodemographic variables were significantly associated with the type of dialysis treatment received by CKD patients.
TABLE 2: Comparison of Quality of life scores adults CKD V on HD
QOL | HD | PD | P value |
Physical health | 3.05 ± 0.6261 | 3.27 ± 0.5015 | 0.122 (There is no significant difference on the average physical health scores between the HD and PD patients.) |
Psychological health | 3.29 ± 0.6178 | 3.45 ± 0.5112 | 0.250 (There is no significant difference on the average psychological health scores between the HD and PD patients.) |
Social Relationships | 3.56 ± 0.6347 | 3.63 ± 0.7734 | 0.091 (There is no significant difference on the average social relationships scores between the HD and PD patients.) |
Environmental health | 3.39 ± 0.6563 | 3.56 ± 0.529 | 0.223 (There is no significant difference on the average environmental health scores between the HD and PD patients.) |
OVER-ALL QUALITY OF LIFE | 3.03 ± 0.9014 | 3.27 ± 1.002 | 0.284 (There is no significant difference on the average over-all quality of life scores between the HD and PD patients.) |
SATISFACTION WITH HEALTH | 2.72 ± 0.9931 | 3.46 ± 0.7060 | 0.001 (There is a significant difference on the average satisfaction with health scores between the HD and PD patients.) |
Table 2 shows the Comparison of quality of life scores among hemodialysis and peritoneal dialysis patients. It showed that there is no significant difference on the average quality of life scores in terms of physical health, psychological, social, environmental and overall health of the CKD patients undergoing HD and patients undergoing PD. Whereas, there is a significant difference Satisfaction with health, of the CKD patients undergoing HD and PD, with PD having a higher domain scores reflecting better quality of life.
DISCUSSION
This study compared 86 adult CKD patients undergoing either hemodialysis (HD) or peritoneal dialysis (PD), highlighting differences in clinicodemographic characteristics and their association with dialysis type. The clinicodemographic traits of patients receiving HD and PD did not differ significantly in this study. There was no statistically significant correlation between the type of dialysis modality and factors like age, sex, comorbidity status, WHO performance status, or place of residence. Additionally, both patient groups received steady financial and social support, which might have helped them access treatment options. These imply that, in our context, clinical judgment, resource availability, or patient preference are probably more important factors in determining the choice between hemodialysis and peritoneal dialysis than demographic or baseline clinical characteristics.
Using the WHOQOL-BREF instrument the study also evaluated several aspects of quality of life (QoL), such as physical, psychological, social, environmental, and general well-being, using the WHOQOL-BREF instrument. According to the results, the average scores for each of these domains did not significantly differ between the HD and PD groups. However, PD patients score higher on health satisfaction, which differ significantly with HD patients (p = 0.001). This is also consistent with earlier research indicating that patients prefer PD in terms of control and general well-being.
Previous studies also showed mixed findings on QoL comparisons between HD and PD. While several studies (e.g., Joshi et al., Goncalves et al., and Depaynos et al.) support the notion that PD offers better QoL due to its flexibility and fewer restrictions, other research (e.g., Chin et al., Wakeel et al., and Wu et al.) suggests that HD patients may benefit from more structured care and support, resulting in better physical functioning. These contrasting perspectives highlight that QoL is multifactorial and influenced by both treatment-related and personal variables, including mental health, social support, comorbid conditions, and healthcare access.